Form 4: Atara Biotherapeutics Executive Jill Henrich Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Jill Henrich, EVP at Atara Biotherapeutics, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On May 16, 2024, Jill Henrich, EVP at Atara Biotherapeutics, sold 25,750 shares of common stock at a price of $0.617 per share.
- The sale was executed to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units.
- Following the transaction, Henrich directly owns 529,251 shares of Atara Biotherapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | Date of stock sale transaction |
| 05/20/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.